Data / Drug companies / Has Healthcare Advanced Synthesis SA
Has Healthcare Advanced Synthesis SA: 12 products in the FDA NDC directory, labeler code 67262
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Has Healthcare Advanced Synthesis SA (labeler code 67262) lists 12 products in the FDA National Drug Code Directory. By type: 12 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on December 29, 2024.
The request: Watch Has Healthcare Advanced Synthesis SA (FDA labeler code 67262): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 67262
- Products in commercial distribution
- 12
- Packages
- 12
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- September 15, 2003
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 12 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 12 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 9 | 75% |
| Liquid | 2 | 16.7% |
| Powder, for solution | 1 | 8.3% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Crinecerfont | 67262-5000 | Powder | Bulk ingredients | December 29, 2024 |
| Lofexidine hydrochloride | 67262-0011 | Powder | Bulk ingredients | May 16, 2018 |
| Glycerol phenylbutyrate | 67262-0009 | Liquid | Bulk ingredients | January 1, 2017 |
| Anamorelin hydrochloride | 67262-0006 | Powder | Bulk ingredients | January 1, 2014 |
| Glycerol phenylbutyrate | 67262-0008 | Liquid | Bulk ingredients | April 1, 2013 |
| Carfilzomib | 67262-0010 | Powder, for solution | Bulk ingredients | July 20, 2012 |
| Cysteamine hydrochloride | 67262-0007 | Powder | Bulk ingredients | January 1, 2012 |
| Bexarotene | 67262-0005 | Powder | Bulk ingredients | January 1, 2012 |
| Bexarotene | 67262-0005 | Powder | Bulk ingredients | January 1, 2012 |
| Isotretinoin | 67262-0003 | Powder | Bulk ingredients | January 1, 2012 |
| Dantrolene sodium | 67262-2000 | Powder | Bulk ingredients | October 1, 2007 |
| Palonosetron hydrochloride | 67262-0001 | Powder | Bulk ingredients | September 15, 2003 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.